The company's fundamentals are relatively weak. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a . Despite a strong stock market performance and outperforming fundamentals, the technicals don't support the current trend. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Vsee Health Inc's Score
Industry at a Glance
Industry Ranking
255 / 485
Overall Ranking
481 / 4616
Industry
Software & IT Services
Support & Resistance
No Data
Score Analysis
Current score
Previous score
Analyst Rating
Based on
0
analysts
--
Current Rating
5.000
Target Price
+278.79%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Vsee Health Inc Highlights
StrengthsRisks
VSee Health, Inc. operates through its subsidiaries, VSee Lab, Inc. (VSee) and iDoc Virtual Telehealth Solutions, Inc. (iDoc). VSee is a no-code or low-code software as a service (SaaS) platform that enables clinicians and enterprises to create their telehealth workflows without programming. VSee’s system allows a telehealth mobile app to be created or a telehealth system to be integrated into existing hospital operations in days. VSee provides patient engagement solutions, clinician staffing solutions, remote physical exam and remote patient monitoring solutions, and AI for telesitter and telenursing solutions. iDoc is an acute care organization that treats and coordinates care for acutely ill patients 24/7 in the neurointensive care unit (Neuro-ICU), cardiac surgery intensive care unit (CSICU) and the intensive care unit (ICU) for stroke, brain trauma and a broad range of neurological conditions. iDoc is a provider of teleneurointensivists for neuro-critical care.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 63.40% year-on-year.
Growing
The company is in a growing phase, with the latest annual income totaling USD 10.42M.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 10.42M.
Overvalued
The company’s latest PE is -0.17, at a high 3-year percentile range.
Institutional Buying
The latest institutional holdings are 1.34M shares, increasing 7.58% quarter-over-quarter.
VSee Health, Inc. operates through its subsidiaries, VSee Lab, Inc. (VSee) and iDoc Virtual Telehealth Solutions, Inc. (iDoc). VSee is a no-code or low-code software as a service (SaaS) platform that enables clinicians and enterprises to create their telehealth workflows without programming. VSee’s system allows a telehealth mobile app to be created or a telehealth system to be integrated into existing hospital operations in days. VSee provides patient engagement solutions, clinician staffing solutions, remote physical exam and remote patient monitoring solutions, and AI for telesitter and telenursing solutions. iDoc is an acute care organization that treats and coordinates care for acutely ill patients 24/7 in the neurointensive care unit (Neuro-ICU), cardiac surgery intensive care unit (CSICU) and the intensive care unit (ICU) for stroke, brain trauma and a broad range of neurological conditions. iDoc is a provider of teleneurointensivists for neuro-critical care.